ReviewArchives of dermatological research2025
Advancing frontiers in skin offensive odor management: from innovative diagnostics to cutting-edge treatments and emerging technologies.
Review in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin bromhidrosis, commonly referred to as body odor, is caused by the microbial breakdown of sweat, leading to the formation of volatile organic compounds (VOCs) that result in unpleasant odors. While body odor is a natural consequence of sweat production, excessive or persistent odor can significantly affect quality of life, causing social stigma and psychological distress. Traditional approaches to managing body odor, such as antiperspirants and deodorants, have limitations, necessitating the development of more advanced diagnostic tools and treatments. This review aims to explore recent advancements in the diagnosis and treatment of skin offensive odor, focusing on cutting-edge technologies and novel approaches. It highlights the interplay of the skin microbiome, sweat gland activity, and external factors in odor formation and investigates innovative solutions for long-term odor management. Emerging diagnostic techniques, such as electronic nose (E-nose) technology, gas chromatography-mass spectrometry (GC-MS), and next-generation sequencing (NGS), enable precise detection and analysis of odor-causing VOCs and microbial profiles. These tools facilitate a deeper understanding of the pathophysiology of odor production. Treatment innovations include nanotechnology-based antimicrobials (e.g., silver and zinc oxide nanoparticles), probiotic formulations for microbiome modulation, and odor-neutralizing compounds such as cyclodextrins and enzymatic neutralizers. Advanced delivery systems, including microneedle patches and nanoencapsulation, enable targeted, sustained release of active ingredients. Additionally, systemic approaches like oral probiotics and dietary interventions offer complementary strategies for managing body odor. The integration of novel diagnostics with innovative topical and systemic treatments offers promising avenues for more effective and personalized management of skin offensive odor. These advancements pave the way for improved quality of life for individuals affected by bromhidrosis, with potential for widespread application in personal care and medical contexts. Clinical trial number: Not applicable.
Indexed as
Identifiers
40056222What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.